Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell entities : Johnson & johnson save search
France CAR-T Cell Therapy Market 2018-2028F - Expansion of Indications Beyond Hematological Malignancies
Published: 2024-02-09 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
MO 4 | $42.09 1.91% -0.42% 22M
|
Consumer Non-Durables
|
| O: -0.35%
H: 0.5%
C: 0.4%
beyond cell expansion car-t therapy market
CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio
Published: 2023-09-25 (Crawled : 21:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
MESO | $5.19 1.57% 1.54% 230K
|
Health Technology
|
| O: -3.28%
H: 5.93%
C: 4.24%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.32%
H: 1.81%
C: 1.23%
companies t-cell therapy growth market
Global CAR-T Cell Therapy Market Report 2023: Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth
Published: 2023-07-06 (Crawled : 19:00) - prnewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: 0.32%
H: 25.69%
C: 21.83%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.7%
H: 0.36%
C: -0.76%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.5%
H: 0.14%
C: -1.45%
report t-cell cell global car-t therapy growth market
LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development
Published: 2023-06-01 (Crawled : 20:00) - globenewswire.com
LVTX | $2.72 -3.89% -4.04% 130K
|
|
| O: 23.16%
H: 61.97%
C: 11.11%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.12%
H: 1.67%
C: 1.45%
antibody t-cell therapeutics
Nexcella Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells
Published: 2023-03-31 (Crawled : 18:00) - biospace.com/
IMMX | $2.21 0.0% 64K
|
|
| O: 2.33%
H: 6.24%
C: 3.41%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.23%
H: 0.91%
C: 0.79%
nxc-201 drug approved food
Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells
Published: 2023-03-31 (Crawled : 12:20) - globenewswire.com
IMMX | $2.21 0.0% 64K
|
|
| O: 2.33%
H: 6.24%
C: 3.41%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.23%
H: 0.91%
C: 0.79%
nxc-201 drug approved food biopharma
CAR T-cell Therapy Pipeline Analysis Demonstrates 450+ Novel Therapies at the Horizon Expected to Transform the Treatment Paradigm | DelveInsight
Published: 2022-11-07 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
treatment t-cell expected therapy
U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-25 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
treatment fda antibody t-cell
Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics
Published: 2022-05-03 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.59%
H: 0.96%
C: -0.04%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: 0.0%
t-cell therapeutics
U.S. FDA Approves CARVYKTI™ (ciltacabtagene autoleucel), Janssen's First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-03-01 (Crawled : 02:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
treatment fda car-t cel immunotherapy therapy
Research Roundup: How COVID-19 Vaccines Train T Cells and More Research News
Published: 2022-01-28 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.57%
C: 0.54%
covid-19 research covid cel vaccine t-cell train
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -5.96%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
cel therapy t-cell
Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market Report 2021-2026: Competitor Landscape, Opportunity Assessment, Approved Drugs, Drugs Patent, Price and Sales insights
Published: 2021-12-20 (Crawled : 19:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.02%
C: -0.51%
sales drug patent cel therapy t-cell
Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses
Published: 2021-12-05 (Crawled : 00:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: 0.0%
covid antibody t-cell
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.87%
H: 5.64%
C: 5.37%
treatment collaboration antibody license t-cell
Global CAR-T Cell Therapy Markets to 2026: Rising Clinical Trials and Development of New and Effective Therapy Options
Published: 2021-09-28 (Crawled : 16:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.12%
H: 1.77%
C: -0.99%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.04%
C: -0.51%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.5%
C: -0.18%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.09%
H: 0.93%
C: -0.26%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: -1.12%
H: 0.52%
C: -2.17%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: -2.67%
H: 1.27%
C: -5.48%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.38%
H: 1.16%
C: -0.01%
clinical trials therapy car-t trials trial t-cell
T Cells: The Forgotten Warrior in the COVID-19 Battle
Published: 2021-07-28 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.04%
H: 0.38%
C: -0.32%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.0%
H: 1.05%
C: 0.59%
covid covid-19 t-cell
New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern
Published: 2021-06-09 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.37%
H: 1.09%
C: 0.98%
ADPT | $2.41 3.21% 3.11% 2.3M
|
Commercial Services
|
| O: 0.82%
H: 3.0%
C: 0.59%
covid vaccine t-cell sars-cov-2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.